Rapid pathogen Opportunity to position Check4 as a rapid, low-cost alternative or complement to PCR in clinical, point-of-care, and remote monitoring settings, targeting hospitals, clinics, and telehealth networks seeking faster turnaround and reduced reagent use.

Graphene tech Leverage graphene-based sensor platform to upsell to diagnostics vendors, contract manufacturers, and research labs interested in scalable, reusable readers and multiplexed tests for food safety, environmental monitoring, and public health surveillance.

Mobile reader Market the reader’s smartphone integration and cloud connectivity to enterprise customers with remote data analytics needs, including healthcare systems, laboratories, and food manufacturers seeking digital record-keeping and real-time dashboards.

Strategic partnerships Capitalize on past collaborations (Jabil, East West Manufacturing, Trek federation) to pursue manufacturing, distribution, or NGO partnerships in turnkey device production, regulatory affairs, and global distribution channels.

Funding momentum Use the recent $20M funding to accelerate commercial deployments, scale production, and fund regional pilots; target strategic investors, government health programs, and large life sciences distributors to widen market access.